SEC Comment Letter for BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477) (BMRN) — Oct 13, 2010

BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477)
Date: Oct. 13, 2010 · CIK: 0001048477 · Accession: 0000000000-10-060279

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-26727

Date

October 13, 2010

Author

Melissa Rocha

Form

UPLOAD

Company

BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477)

Letter

October 13, 2010 Jeffrey H. Cooper Senior Vice President, Chief Financial Officer BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 Re: BioMarin Pharmaceutical Inc. Form 10-K for the Fiscal Year Ended December 31, 2009 Filed February 26, 2010 Proxy Statement on Schedule 14A Filed March 26, 2010 File Number: 000-26727

Dear Mr. Cooper: We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely,

Melissa Rocha Accounting Branch Chief

Show Raw Text

October 13, 2010
 Jeffrey H. Cooper Senior Vice President, Chief Financial Officer
BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949
Re:  BioMarin Pharmaceutical Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2009
  Filed February 26, 2010
  Proxy Statement on Schedule 14A
  Filed March 26, 2010
 File Number: 000-26727

Dear Mr. Cooper:   We have completed our review of your fili ngs and do not have any further comments at
this time.
Sincerely,

Melissa Rocha
Accounting Branch Chief

SecProbe.io